CK2 targeted RNAi therapeutic delivered via malignant cell-directed tenfibgen nanocapsule: dose and molecular mechanisms of response in xenograft prostate tumors

CK2, a protein serine/threonine kinase, promotes cell proliferation and suppresses cell death. This essential-for-survival signal demonstrates elevated expression and activity in all cancers examined, and is considered an attractive target for cancer therapy. Here, we present data on the efficacy of...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Oncotarget
Päätekijät: Ahmed, Khalil, Kren, Betsy T., Abedin, Md. Joynal, Vogel, Rachel I., Shaughnessy, Daniel P., Nacusi, Lucas, Korman, Vicci L., Li, Yingming, Dehm, Scott M., Zimmerman, Cheryl L., Niehans, Gloria A., Unger, Gretchen M., Trembley, Janeen H.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Impact Journals LLC 2016
Aiheet:
Research Paper
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5308691/
https://ncbi.nlm.nih.gov/pubmed/27557516
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.11442
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia